Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)

NCT03342352 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was cancelled prior to enrolling any patients.

Conditions

Head and Neck Cancer

Interventions

DRUG: Nivolumab
DRUG: Epacadostat
DRUG: Placebo
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Cetuximab
DRUG: 5-Fluorouracil

Sponsor

Incyte Corporation

Collaborators

[object Object]